1974
DOI: 10.1007/978-3-642-49284-6_21
|View full text |Cite
|
Sign up to set email alerts
|

Experimental Screening for “Systemic Adjuvants of Immunity” Applicable in Cancer Immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
18
0

Year Published

1976
1976
1984
1984

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(19 citation statements)
references
References 17 publications
1
18
0
Order By: Relevance
“…However, only a few publications are available concerning the in vivo antitumor effect of the water-soluble substances. Mathe et al (1973Mathe et al ( , 1975 reported that a water soluble substance from BCG described by Hiu (1972) was not effective in an attempt of immunoprophylaxis against murine neoplasms. Cantrell and Wheat (1979) reported that inoculation into mice of a mixture of tumor cells and a hot phenol-water extract from Corynebacterium parvum provided no significant protection.…”
Section: Discussionmentioning
confidence: 99%
“…However, only a few publications are available concerning the in vivo antitumor effect of the water-soluble substances. Mathe et al (1973Mathe et al ( , 1975 reported that a water soluble substance from BCG described by Hiu (1972) was not effective in an attempt of immunoprophylaxis against murine neoplasms. Cantrell and Wheat (1979) reported that inoculation into mice of a mixture of tumor cells and a hot phenol-water extract from Corynebacterium parvum provided no significant protection.…”
Section: Discussionmentioning
confidence: 99%
“…Mathe et al (1973) compared the immunoprophylactic effects of BCG, MER, C. parvum, poly I-poly C and poly A-poly U administration before tumour (L 1210 and Lewis lung tumour) inoculation, and observed no significant increases in survival times. Proctor et al (1977) found that BCG, levamisole and glucan administered in 4 dose levels (2, 5, 25 and 250 pg/mouse) i.p.…”
Section: Discussionmentioning
confidence: 99%
“…Adjuvant effect of MAF3 and other fractions of water-extract on antibody production to EA in guinea pigs could not be confirmed in BDF1 mice [8]. Therefore, it is necessary to define the relation between the chemical structure and biological properties of the adjuvant-active component in MAF3.…”
Section: Discussionmentioning
confidence: 99%
“…In 1972, Hiu reported that MAAF (mycobacterial adjuvant and antitumor fraction)2 was prepared by hydrogenolysis from the delipidated cells of Mycobacterium bovis strain BCG and had sufficient potency to heighten the population of direct plaque-forming cells in spleen against sheep erythrocytes, to induce delayed type hypersensitivity (DTH) against egg albumin (EA), and to protect against death from leukemia by murine L 1210 tumor cells [6]. Mathe et al, however, reported that the antitumor activity of MAAF could not be demonstrated for L1210 cells in BDF1 mice and for Lewis tumor cells in Lewis rats [8]. We attempted to confirm whether or not a water-soluble adjuvant can be prepared from delipidated cells of a virulent human type of mycobacteria by the hydrogenolysis described by Hiu [6] and gel filtration with a Sephadex G-100 column Requests Analytical procedures.…”
mentioning
confidence: 99%